Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03349411 · ClinicalTrials.gov registry record
Spatial Neglect and Delirium After Stroke
A clinical trial, sponsored by Kessler Foundation.
- Completed
- Registry status
- 45
- Enrollment target
NCT03349411 is a clinical trial that has completed, run by Kessler Foundation. The registered enrollment target is 45 participants.
The verdict
NCT03349411 has completed, sponsored by Kessler Foundation.
- COMPLETED
- Registry status
- 45 participants
- Enrollment target
Study Summary
The goal of this study is to understand what brain mechanisms become disrupted when stroke survivors experience delirium. Delirium is an acute reduction in attention and cognition, associated with poor recovery, longer hospitalization and even death. One major factor increasing the risk of delirium after stroke may be spatial neglect occurring after stroke on the right side of the brain. Spatial neglect affects awareness, orientation, and movement. The study will test the hypothesis that the right-dominant brain networks for arousal and attention are affected in both of these disorders. It is expected that the activity and structural integrity of these brain networks will correlate with behavioral signs and severity of delirium and spatial neglect. To test this hypothesis, the study will measure spatial neglect and delirium symptoms in 45 acute (NYC Health + Hospitals/Bellevue ) and 30 subacute (Kessler Institute for Rehabilitation) stroke survivors and evaluate brain scans for these participants. This study may contribute to knowledge about brain bio-markers of delirium, which will greatly aid in delirium detection in stroke and other disorders.
Interventions
- DIAGNOSTIC_TEST Magnetic Resonance Imaging
- DIAGNOSTIC_TEST Confusion Assessment Method
- DIAGNOSTIC_TEST Behavioral Inattention Test
- DIAGNOSTIC_TEST Florida Mental Status Examination
- DIAGNOSTIC_TEST Montreal Cognitive Assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2017-07-18 |
| Est. Completion | 2020-12-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03349411
The ClinicalTrials.gov registry entry for NCT03349411 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kessler Foundation, which has 104 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Magnetic Resonance Imaging is the first listed.
NCT03349411 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03349411 about?
NCT03349411 is a clinical study titled "Spatial Neglect and Delirium After Stroke". The goal of this study is to understand what brain mechanisms become disrupted when stroke survivors experience delirium. Delirium is an acute reduction in attention and cognition, associated with poor recovery, longer hospitalization and even death. One major factor increasing the risk of delirium ...
What is the current status of trial NCT03349411?
This trial is currently completed. The enrollment target is 45 participants. The study started on 2017-07-18. Estimated completion is 2020-12-30.
What interventions are being tested in trial NCT03349411?
The interventions under investigation include: Magnetic Resonance Imaging (DIAGNOSTIC_TEST), Confusion Assessment Method (DIAGNOSTIC_TEST), Behavioral Inattention Test (DIAGNOSTIC_TEST), Florida Mental Status Examination (DIAGNOSTIC_TEST), Montreal Cognitive Assessment (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03349411?
This trial is sponsored by Kessler Foundation, which has 104 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.